TY - JOUR
T1 - A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease
AU - Sutherland, Greg
AU - Mellick, George
AU - Sue, Carolyn
AU - Chan, Daniel K Y
AU - Rowe, Dominic
AU - Silburn, Peter
AU - Halliday, Glenda
PY - 2007/3/6
Y1 - 2007/3/6
N2 - Mutations in the parkin gene are the major cause of autosomal recessive early-onset forms of Parkinson's disease (PD). As reduced parkin expression might also affect the clinical course of idiopathic PD we investigated the effect of a low expressing allele in the parkin promoter region on the age at disease onset (AAO). Patients with PD (n = 175) fulfilling standard diagnostic criteria were recruited by experienced neurologists at two movement disorders clinics in Sydney and Brisbane, Australia. DNA was extracted from whole blood and the -258 T/G polymorphism genotyped using PCR/RFLP. AAO effects were analysed using univariate ANOVA, binomial logistic regression modelling and Kaplan-Meier survival analysis. Subjects with the GG genotype (n = 10, mean AAO = 46.2 ± 11.5 (S.D.) years) had a significantly lower mean AAO compared to the common TT genotype (n = 104, mean AAO = 56.1 ± 12.7, p = 0.02). There was no difference in mean AAO between the TT and TG individuals (n = 61, mean AAO = 55.3 ± 11.6). Stratifying the sample by median AAO (55 years) revealed that the GG genotype was over-represented in the early-onset group (n = 9, OR = 18.6, 95% CI = 1.41-245.3, p = 0.03). We speculate that reduced expression of normal parkin protein may result in an early manifestation of PD symptoms.
AB - Mutations in the parkin gene are the major cause of autosomal recessive early-onset forms of Parkinson's disease (PD). As reduced parkin expression might also affect the clinical course of idiopathic PD we investigated the effect of a low expressing allele in the parkin promoter region on the age at disease onset (AAO). Patients with PD (n = 175) fulfilling standard diagnostic criteria were recruited by experienced neurologists at two movement disorders clinics in Sydney and Brisbane, Australia. DNA was extracted from whole blood and the -258 T/G polymorphism genotyped using PCR/RFLP. AAO effects were analysed using univariate ANOVA, binomial logistic regression modelling and Kaplan-Meier survival analysis. Subjects with the GG genotype (n = 10, mean AAO = 46.2 ± 11.5 (S.D.) years) had a significantly lower mean AAO compared to the common TT genotype (n = 104, mean AAO = 56.1 ± 12.7, p = 0.02). There was no difference in mean AAO between the TT and TG individuals (n = 61, mean AAO = 55.3 ± 11.6). Stratifying the sample by median AAO (55 years) revealed that the GG genotype was over-represented in the early-onset group (n = 9, OR = 18.6, 95% CI = 1.41-245.3, p = 0.03). We speculate that reduced expression of normal parkin protein may result in an early manifestation of PD symptoms.
KW - Genotype
KW - Onset
KW - Parkin
KW - Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=33847067038&partnerID=8YFLogxK
U2 - 10.1016/j.neulet.2006.12.051
DO - 10.1016/j.neulet.2006.12.051
M3 - Article
C2 - 17280783
AN - SCOPUS:33847067038
SN - 0304-3940
VL - 414
SP - 170
EP - 173
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 2
ER -